Copyright Reports & Markets. All rights reserved.

Europe Compounding Pharmacies Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Compounding Pharmacies Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Oral Market Performance (Volume)
      • 2.1.2 Topical Market Performance (Volume)
      • 2.1.3 Ophthalmic Market Performance (Volume)
      • 2.1.4 Injectables Market Performance (Volume)
      • 2.1.5 Others Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Oral Market Performance (Value)
      • 2.2.2 Topical Market Performance (Value)
      • 2.2.3 Ophthalmic Market Performance (Value)
      • 2.2.4 Injectables Market Performance (Value)
      • 2.2.5 Others Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Adult Market Performance (Volume)
      • 3.1.2 Pediatric Market Performance (Volume)
      • 3.1.3 Geriatric Market Performance (Volume)
      • 3.1.4 Veterinary Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Fagron
      • 4.1.1 Fagron Profiles
      • 4.1.2 Fagron Product Information
      • 4.1.3 Fagron Compounding Pharmacies Business Performance
      • 4.1.4 Fagron Compounding Pharmacies Business Development and Market Status
    • 4.2 PharMEDium
      • 4.2.1 PharMEDium Profiles
      • 4.2.2 PharMEDium Product Information
      • 4.2.3 PharMEDium Compounding Pharmacies Business Performance
      • 4.2.4 PharMEDium Compounding Pharmacies Business Development and Market Status
    • 4.3 Dougherty's Pharmacy
      • 4.3.1 Dougherty's Pharmacy Profiles
      • 4.3.2 Dougherty's Pharmacy Product Information
      • 4.3.3 Dougherty's Pharmacy Compounding Pharmacies Business Performance
      • 4.3.4 Dougherty's Pharmacy Compounding Pharmacies Business Development and Market Status
    • 4.4 ITC Compounding Pharmacy
      • 4.4.1 ITC Compounding Pharmacy Profiles
      • 4.4.2 ITC Compounding Pharmacy Product Information
      • 4.4.3 ITC Compounding Pharmacy Compounding Pharmacies Business Performance
      • 4.4.4 ITC Compounding Pharmacy Compounding Pharmacies Business Development and Market Status
    • 4.5 Fresenius Kabi
      • 4.5.1 Fresenius Kabi Profiles
      • 4.5.2 Fresenius Kabi Product Information
      • 4.5.3 Fresenius Kabi Compounding Pharmacies Business Performance
      • 4.5.4 Fresenius Kabi Compounding Pharmacies Business Development and Market Status
    • 4.6 Clinigen Group
      • 4.6.1 Clinigen Group Profiles
      • 4.6.2 Clinigen Group Product Information
      • 4.6.3 Clinigen Group Compounding Pharmacies Business Performance
      • 4.6.4 Clinigen Group Compounding Pharmacies Business Development and Market Status
    • 4.7 Absolute Pharmacy
      • 4.7.1 Absolute Pharmacy Profiles
      • 4.7.2 Absolute Pharmacy Product Information
      • 4.7.3 Absolute Pharmacy Compounding Pharmacies Business Performance
      • 4.7.4 Absolute Pharmacy Compounding Pharmacies Business Development and Market Status
    • 4.8 McGuff Compounding Pharmacy Services
      • 4.8.1 McGuff Compounding Pharmacy Services Profiles
      • 4.8.2 McGuff Compounding Pharmacy Services Product Information
      • 4.8.3 McGuff Compounding Pharmacy Services Compounding Pharmacies Business Performance
      • 4.8.4 McGuff Compounding Pharmacy Services Compounding Pharmacies Business Development and Market Status
    • 4.9 Harrow Health
      • 4.9.1 Harrow Health Profiles
      • 4.9.2 Harrow Health Product Information
      • 4.9.3 Harrow Health Compounding Pharmacies Business Performance
      • 4.9.4 Harrow Health Compounding Pharmacies Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Europe Compounding Pharmacies Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Europe Compounding Pharmacies Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Europe Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Europe Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 Germany Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 Germany Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 Germany Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 UK Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 UK Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 UK Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 France Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 France Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 France Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Russia Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Russia Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Russia Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Benelux Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Benelux Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Benelux Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 Italy Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 Italy Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 Italy Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Spain Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Spain Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Spain Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Compounding Pharmacies Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 Compounding Pharmacies Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 Compounding Pharmacies Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 Compounding Pharmacies Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Europe Compounding Pharmacies Market Performance (Sales Point)

    • 7.1 Europe Compounding Pharmacies Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Europe Compounding Pharmacies Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Europe Compounding Pharmacies Price (USD/Unit) by Regions 2014-2020
    • 7.4 Europe Compounding Pharmacies Gross Margin by Regions 2014-2020

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.2 Germany Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.3 UK Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 France Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.5 Russia Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.6 Benelux Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.7 Italy Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.8 Spain Compounding Pharmacies Sales and Growth, Sales Value and Growth Rate2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Adult Industry
    • 11.2 Pediatric Industry
    • 11.3 Geriatric Industry
    • 11.4 Veterinary Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Europe Compounding Pharmacies Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Europe Compounding Pharmacies Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Germany Compounding Pharmacies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 UK Compounding Pharmacies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 France Compounding Pharmacies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Russia Compounding Pharmacies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Benelux Compounding Pharmacies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Italy Compounding Pharmacies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Spain Compounding Pharmacies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Oral Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.3 Topical Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.4 Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.5 Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.6 Others Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Adult Sales and and Growth Rate 2021-2026
      • 12.3.3 Pediatric Sales and and Growth Rate 2021-2026
      • 12.3.4 Geriatric Sales and and Growth Rate 2021-2026
      • 12.3.5 Veterinary Sales and and Growth Rate 2021-2026
    • 12.4 Price (USD/Unit) and Gross Profit Forecast
      • 12.4.1 Europe Compounding Pharmacies Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Europe Compounding Pharmacies Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, the Compounding Pharmacies market is expected to be valued at USD xxx billion by 2026, growing at a CAGR of xx% between 2020 and 2026. In this study, sales and sales value (million USD) of major players in Europe market will be included.
    Sales and revenue by type/application from 2014-2026.
    Industry chain, market trend, downstream and upstream information is also included.

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Compounding Pharmacies for these regions, from 2014 to 2026 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Compounding Pharmacies market competition by top manufacturers/players, with Compounding Pharmacies sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Fagron
    PharMEDium
    Dougherty's Pharmacy
    ITC Compounding Pharmacy
    Fresenius Kabi
    Clinigen Group
    Absolute Pharmacy
    McGuff Compounding Pharmacy Services
    Harrow Health

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Oral
    Topical
    Ophthalmic
    Injectables
    Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Compounding Pharmacies for each application, including
    Adult
    Pediatric
    Geriatric
    Veterinary

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now